Adiponectin protects against cardiac fibrosis but not the formation of atherosclerotic lesions in LDL receptor deficient mice

被引：0
|
作者：
Nawrocki, A. R. [1 ]
Hofmann, S. M. [2 ]
Teupser, D. [3 ]
Basford, J. E. [2 ]
Rickes, E. L. [1 ]
Tanowitz, H. B. [4 ]
Chang, C. H. [1 ]
Hui, D. Y. [2 ]
Scherer, P. E. [5 ]
机构：
[1] Merck Res Labs, Rahway, NJ USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[3] Univ Hosp Leipzig, Leipzig, Germany
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2008年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [31] Vaccination against interleukin 12 attenuates atherosclerosis in LDL receptor deficient mice
    Hauer, A
    Uyttenhove, C
    de Vos, P
    Stroobant, V
    Renauld, J
    van Berkel, T
    van Snick, J
    Kuiper, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 41 - 42
  • [32] Partial hexokinase II deficiency does not accelerate the formation of diet-induced atherosclerotic lesions in LDL receptor null mice
    Heikkinen, S
    Lappänen, P
    Pirinen, E
    Jänne, J
    Ylä-Herttuala, S
    Laakso, M
    DIABETES, 2002, 51 : A176 - A176
  • [33] Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice
    Collins, AR
    Meehan, WP
    Kintscher, U
    Jackson, S
    Wakino, S
    Noh, G
    Palinski, W
    Hsueh, WA
    Law, RE
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 365 - 371
  • [34] Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice
    Tian, Jing
    Pei, Hong
    Sanders, John M.
    Angle, John F.
    Sarembock, Ian J.
    Matsumoto, Alan H.
    Helm, Gregory A.
    Shi, Weibin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (03) : 1004 - 1009
  • [35] Lymphocyte populations in atherosclerotic lesions of ApoE -/- and LDL receptor -/- mice - Decreasing density with disease progression
    Roselaar, SE
    Kakkanathu, PX
    Daugherty, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) : 1013 - 1018
  • [36] Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice
    Venu, Vivek Krishna Pulakazhi
    Uboldi, Patrizia
    Dhyani, Ashish
    Patrini, Alessandro
    Baetta, Roberta
    Ferri, Nicola
    Corsini, Alberto
    Muro, Andres F.
    Catapano, Alberico Luigi
    Norata, Giuseppe Danilo
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 186 - 197
  • [37] Role of glutathione in macrophage injury and atherosclerotic lesion development in LDL receptor-deficient mice.
    Asmis, R.
    Kisgati, M.
    Wang, Y.
    Zhu, W.
    Cholewa, J. M.
    Mieyal, J. J.
    Qiao, M.
    FREE RADICAL RESEARCH, 2006, 40 : S147 - S147
  • [38] Role of macrophages in the unique atherosclerotic lesion morphology of LDL receptor-deficient mice with a Lystbeige mutation
    Schiller, N
    Black, A
    Bradshaw, G
    Bonnet, D
    Curtiss, L
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 78 - 78
  • [39] BIOMECHANICAL MODELING OF ATHEROSCLEROTIC LESIONS IN ApoE DEFICIENT MICE
    Vengrenyuk, Yuliya
    Kaplan, Theodore J.
    Cardoso, Luis
    Randolph, Gwendalyn J.
    Weinbaum, Sheldon
    PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2009, PT A AND B, 2009, : 185 - 186
  • [40] Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice:: An immunohistochemical study
    Ström, Å
    Ahlqvist, E
    Franzén, A
    Heinegård, D
    Huitgårdh-Nilsson, A
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (02) : 337 - 347
12345